enVVeno Medical (NVNO) Gross Margin (2017 - 2019)

enVVeno Medical's (NVNO) quarterly Gross Margin came in at 100.0% in Q1 2019, little changed quarter-over-quarter from 100.0% in Q4 2018.

enVVeno Medical (NVNO) Gross Margin (2017 - 2019) Analysis & Trends

enVVeno Medical's Gross Margin history runs 3 years deep, the most recent figure standing at 100.0% for Q1 2019.

  • On a quarterly basis, Gross Margin changed N/A year-over-year to 100.0% in Q1 2019; TTM through Mar 2019 was 100.0%, a N/A change from a year earlier, with the FY2018 full-year figure at 100.0%, up 9942.0% from the prior year.
  • Gross Margin held at 100.0% in Q1 2019 per NVNO's latest filing, from 100.0% in the prior quarter.
  • Across five years, Gross Margin topped out at 100.0% in Q2 2017 and bottomed at 376.83% in Q3 2017.
  • The 3-year median for Gross Margin is 100.0% (2017), against an average of 23.89%.
  • Biggest YoY gain for Gross Margin was 47683 bps in 2018; the steepest drop was 0 bps in 2018.
  • Year by year, Gross Margin stood at 44.05% in 2017, then jumped by 127 bps to 100.0% in 2018, then changed by 0 bps to 100.0% in 2019.
  • Per Business Quant, the three latest NVNO Gross Margin figures stand at 100.0% (Q1 2019), 100.0% (Q4 2018), and 100.0% (Q3 2018).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Abbott Laboratories 183.67 Bn 176.38 Bn 6.27 Bn 56.20%
2 Stryker 128.91 Bn 126.03 Bn 3.81 Bn 63.29%
3 Medtronic 108.84 Bn 99.62 Bn 6.41 Bn 65.35%
4 Boston Scientific 68.57 Bn 67.12 Bn 3.61 Bn 69.46%
5 Edwards Lifesciences 48.68 Bn 45.01 Bn 1.29 Bn 78.01%
6 Dexcom 28.42 Bn 27.31 Bn 750.30 Mn 62.95%
7 GE HealthCare Technologies 28.38 Bn 26.09 Bn 1.98 Bn 38.53%
8 Smith & Nephew 26.94 Bn 26.36 Bn - -
9 Koninklijke Philips 25.50 Bn 22.38 Bn 2.07 Bn 45.22%
10 enVVeno Medical 6.86 Mn 6.86 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2019 100.00%
Dec 31, 2018 100.00%
Sep 30, 2018 100.00%
Jun 30, 2018 100.00%
Dec 31, 2017 44.05%
Sep 30, 2017 -376.83%
Jun 30, 2017 100.00%